JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 2, pp. 167 - 172
Objectives The purpose of this analysis was to evaluate the correlation between atrial tachycardia (AT) or atrial fibrillation (AF) and clinical outcomes in...
Cardiovascular | Internal Medicine | heart failure | clinical outcomes | cardiac resynchronization | atrial tachyarrhythmias | defibrillator | FIBRILLATION | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVERTER-DEFIBRILLATOR | RISK | DEATH | CARDIAC RESYNCHRONIZATION THERAPY | CONGESTIVE-HEART-FAILURE | ATRIOVENTRICULAR JUNCTION ABLATION | Prognosis | Electrocardiography, Ambulatory - instrumentation | Follow-Up Studies | Ventricular Function, Left | Humans | Atrial Fibrillation - complications | Heart Failure - physiopathology | Tachycardia, Ectopic Atrial - diagnosis | Male | Atrial Fibrillation - physiopathology | Tachycardia, Ectopic Atrial - complications | Disease Progression | Stroke Volume | Heart Failure - therapy | Tachycardia, Ectopic Atrial - physiopathology | Time Factors | Defibrillators, Implantable | Female | Aged | Atrial Fibrillation - diagnosis | Heart Failure - etiology | Heart failure | Medical research | Prosthesis | Patient outcomes | Atrial fibrillation | Tachycardia | Defibrillators | Implants, Artificial | Analysis | Cardiac patients | Medicine, Experimental | Cardiology | Heart | Cardiac arrhythmia | Hospitalization | Drug therapy | Clinical outcomes
Cardiovascular | Internal Medicine | heart failure | clinical outcomes | cardiac resynchronization | atrial tachyarrhythmias | defibrillator | FIBRILLATION | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVERTER-DEFIBRILLATOR | RISK | DEATH | CARDIAC RESYNCHRONIZATION THERAPY | CONGESTIVE-HEART-FAILURE | ATRIOVENTRICULAR JUNCTION ABLATION | Prognosis | Electrocardiography, Ambulatory - instrumentation | Follow-Up Studies | Ventricular Function, Left | Humans | Atrial Fibrillation - complications | Heart Failure - physiopathology | Tachycardia, Ectopic Atrial - diagnosis | Male | Atrial Fibrillation - physiopathology | Tachycardia, Ectopic Atrial - complications | Disease Progression | Stroke Volume | Heart Failure - therapy | Tachycardia, Ectopic Atrial - physiopathology | Time Factors | Defibrillators, Implantable | Female | Aged | Atrial Fibrillation - diagnosis | Heart Failure - etiology | Heart failure | Medical research | Prosthesis | Patient outcomes | Atrial fibrillation | Tachycardia | Defibrillators | Implants, Artificial | Analysis | Cardiac patients | Medicine, Experimental | Cardiology | Heart | Cardiac arrhythmia | Hospitalization | Drug therapy | Clinical outcomes
Journal Article
Internal and emergency medicine, ISSN 1828-0447, 09/2019, pp. 1 - 8
The frequency of premature atrial complexes (PACs) has been related with atrial fibrillation (AF) occurrence and adverse prognosis. Research objective was to...
Confidence intervals | Cardiac arrhythmia | Bradycardia | Fibrillation | Audio frequencies | Frequency analysis | Rhythm | Risk analysis
Confidence intervals | Cardiac arrhythmia | Bradycardia | Fibrillation | Audio frequencies | Frequency analysis | Rhythm | Risk analysis
Journal Article
2009, 1. ed., Colección Un cuarto propio, ISBN 9789872428679, 217
Book
Nature Genetics, ISSN 1061-4036, 05/2015, Volume 47, Issue 6, pp. 661 - 667
Zimmermann-Laband syndrome (ZLS) is a developmental disorder characterized by facial dysmorphism with gingival enlargement, intellectual disability, hypoplasia...
V-ATPASE | CELLS | DIFFERENTIAL EXPRESSION | DE-NOVO MUTATION | CANTU SYNDROME | GENETICS & HEREDITY | K(V)10.1 | VACUOLAR H+-ATPASE | LYSOSOMAL ACIDIFICATION | POTASSIUM CHANNEL | SUBUNIT | Vacuolar Proton-Translocating ATPases - genetics | Cricetinae | Cricetulus | Genetic Association Studies | Humans | Xenopus laevis | Models, Molecular | Fibromatosis, Gingival - genetics | Male | Codon, Nonsense | Mutation, Missense | Ether-A-Go-Go Potassium Channels - genetics | Animals | Hand Deformities, Congenital - genetics | Membrane Potentials | Pedigree | Female | Protein Conformation | Abnormalities, Multiple - genetics | Craniofacial Abnormalities - genetics | CHO Cells | Causes of | Genetic research | Genetic disorders | Gene mutations | Identification and classification | Health aspects | Data processing | Data analysis | Genomes | Mutation | Data bases
V-ATPASE | CELLS | DIFFERENTIAL EXPRESSION | DE-NOVO MUTATION | CANTU SYNDROME | GENETICS & HEREDITY | K(V)10.1 | VACUOLAR H+-ATPASE | LYSOSOMAL ACIDIFICATION | POTASSIUM CHANNEL | SUBUNIT | Vacuolar Proton-Translocating ATPases - genetics | Cricetinae | Cricetulus | Genetic Association Studies | Humans | Xenopus laevis | Models, Molecular | Fibromatosis, Gingival - genetics | Male | Codon, Nonsense | Mutation, Missense | Ether-A-Go-Go Potassium Channels - genetics | Animals | Hand Deformities, Congenital - genetics | Membrane Potentials | Pedigree | Female | Protein Conformation | Abnormalities, Multiple - genetics | Craniofacial Abnormalities - genetics | CHO Cells | Causes of | Genetic research | Genetic disorders | Gene mutations | Identification and classification | Health aspects | Data processing | Data analysis | Genomes | Mutation | Data bases
Journal Article
American Heart Journal, ISSN 0002-8703, 2008, Volume 155, Issue 1, pp. 100.e1 - 100.e9
Background Rhythm control is an important goal in the treatment of recurrent atrial tachyarrhythmias (AT). The PITAGORA study was a randomized trial in...
Cardiovascular | Single-Blind Method | Prospective Studies | Follow-Up Studies | Flecainide - administration & dosage | Humans | Male | Reference Values | Amiodarone - administration & dosage | Dose-Response Relationship, Drug | Arrhythmia, Sinus - mortality | Atrial Fibrillation - mortality | Statistics, Nonparametric | Aged, 80 and over | Electrocardiography | Female | Drug Therapy, Combination | Drug Administration Schedule | Risk Assessment | Atrial Fibrillation - drug therapy | Probability | Survival Rate | Treatment Outcome | Arrhythmia, Sinus - diagnosis | Cardiac Pacing, Artificial | Anti-Arrhythmia Agents - administration & dosage | Sotalol - administration & dosage | Arrhythmia, Sinus - therapy | Propafenone - administration & dosage | Aged | Atrial Fibrillation - prevention & control | Integrated circuits | Prevention | Medical research | Atrial fibrillation | Anti-arrhythmia drugs | Clinical trials | Medicine, Experimental | Comparative analysis | Drug therapy | Semiconductor chips | Anticoagulants | Stroke | Heart attacks | Mortality | Cardiovascular disease | Hospitalization | Studies | Disease prevention | Algorithms | Sinuses | Acute coronary syndromes | Drug dosages
Cardiovascular | Single-Blind Method | Prospective Studies | Follow-Up Studies | Flecainide - administration & dosage | Humans | Male | Reference Values | Amiodarone - administration & dosage | Dose-Response Relationship, Drug | Arrhythmia, Sinus - mortality | Atrial Fibrillation - mortality | Statistics, Nonparametric | Aged, 80 and over | Electrocardiography | Female | Drug Therapy, Combination | Drug Administration Schedule | Risk Assessment | Atrial Fibrillation - drug therapy | Probability | Survival Rate | Treatment Outcome | Arrhythmia, Sinus - diagnosis | Cardiac Pacing, Artificial | Anti-Arrhythmia Agents - administration & dosage | Sotalol - administration & dosage | Arrhythmia, Sinus - therapy | Propafenone - administration & dosage | Aged | Atrial Fibrillation - prevention & control | Integrated circuits | Prevention | Medical research | Atrial fibrillation | Anti-arrhythmia drugs | Clinical trials | Medicine, Experimental | Comparative analysis | Drug therapy | Semiconductor chips | Anticoagulants | Stroke | Heart attacks | Mortality | Cardiovascular disease | Hospitalization | Studies | Disease prevention | Algorithms | Sinuses | Acute coronary syndromes | Drug dosages
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 10/2012, Volume 20, Issue 10, pp. 2621 - 2626
Bortezomib, a proteasome inhibitor drug very effective against multiple myeloma, may induce the so-called bortezomib-induced peripheral neuropathy (BIPN),...
Pain Medicine | Rehabilitation Medicine | Nursing | Pain | Bortezomib | Medicine & Public Health | Multiple myeloma | Oncology | Neuropathy | Nursing Management/Nursing Research | MANAGEMENT | PHASE-2 | CARE | TRIAL | INDUCED PERIPHERAL NEUROTOXICITY | ONCOLOGY | HEMATOLOGICAL MALIGNANCIES | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | REVERSIBILITY | ITALIAN SURVEY | EPIDEMIOLOGY | Peripheral Nervous System Diseases - chemically induced | Administration, Oral | Oxycodone - administration & dosage | Humans | Middle Aged | Boronic Acids - adverse effects | Multiple Myeloma - drug therapy | Rome | Analgesics, Opioid - administration & dosage | Antineoplastic Agents - adverse effects | Pyrazines - adverse effects | Aged | Delayed-Action Preparations | Peripheral Nervous System Diseases - drug therapy | Care and treatment | Anticonvulsants | Analgesics | Lymphomas | Side effects | Inhibitor drugs | Neurological disorders | Pain management
Pain Medicine | Rehabilitation Medicine | Nursing | Pain | Bortezomib | Medicine & Public Health | Multiple myeloma | Oncology | Neuropathy | Nursing Management/Nursing Research | MANAGEMENT | PHASE-2 | CARE | TRIAL | INDUCED PERIPHERAL NEUROTOXICITY | ONCOLOGY | HEMATOLOGICAL MALIGNANCIES | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | REVERSIBILITY | ITALIAN SURVEY | EPIDEMIOLOGY | Peripheral Nervous System Diseases - chemically induced | Administration, Oral | Oxycodone - administration & dosage | Humans | Middle Aged | Boronic Acids - adverse effects | Multiple Myeloma - drug therapy | Rome | Analgesics, Opioid - administration & dosage | Antineoplastic Agents - adverse effects | Pyrazines - adverse effects | Aged | Delayed-Action Preparations | Peripheral Nervous System Diseases - drug therapy | Care and treatment | Anticonvulsants | Analgesics | Lymphomas | Side effects | Inhibitor drugs | Neurological disorders | Pain management
Journal Article
Heart Rhythm, ISSN 1547-5271, 2015, Volume 12, Issue 8, pp. 1717 - 1725
Background Atrial fibrillation (AF) is a frequent comorbidity in patients with pacemaker and is a recognized cause of mortality, morbidity, and quality-of-life...
Cardiovascular | Reactive ATP | Antitachycardia pacing | Pacemaker | Atrial fibrillation | UNITED-STATES | CARDIAC & CARDIOVASCULAR SYSTEMS | SINUS NODE DYSFUNCTION | HEART-FAILURE | GUIDELINES | DEVICE | TACHYARRHYTHMIA BURDEN | EUROPEAN-SOCIETY | TRENDS | THERAPY | TASK-FORCE | Pacemaker, Artificial - adverse effects | Follow-Up Studies | Atrial Fibrillation - therapy | Humans | Risk Factors | Bradycardia - therapy | Kaplan-Meier Estimate | Male | Treatment Outcome | Cardiac Pacing, Artificial - adverse effects | Cardiac Pacing, Artificial - methods | Bradycardia - complications | Incidence | Atrial Fibrillation - epidemiology | Time Factors | Aged, 80 and over | Atrial Fibrillation - etiology | Female | Aged | Atrial Fibrillation - prevention & control | Prevention | Heart | Sects | Care and treatment | Comorbidity | Mortality
Cardiovascular | Reactive ATP | Antitachycardia pacing | Pacemaker | Atrial fibrillation | UNITED-STATES | CARDIAC & CARDIOVASCULAR SYSTEMS | SINUS NODE DYSFUNCTION | HEART-FAILURE | GUIDELINES | DEVICE | TACHYARRHYTHMIA BURDEN | EUROPEAN-SOCIETY | TRENDS | THERAPY | TASK-FORCE | Pacemaker, Artificial - adverse effects | Follow-Up Studies | Atrial Fibrillation - therapy | Humans | Risk Factors | Bradycardia - therapy | Kaplan-Meier Estimate | Male | Treatment Outcome | Cardiac Pacing, Artificial - adverse effects | Cardiac Pacing, Artificial - methods | Bradycardia - complications | Incidence | Atrial Fibrillation - epidemiology | Time Factors | Aged, 80 and over | Atrial Fibrillation - etiology | Female | Aged | Atrial Fibrillation - prevention & control | Prevention | Heart | Sects | Care and treatment | Comorbidity | Mortality
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2005, Volume 46, Issue 10, pp. 1913 - 1920
Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With...
CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | RISK-FACTOR | WARFARIN | RANDOMIZED-TRIAL | PATTERNS | DEATH | PREVALENCE | Prospective Studies | Follow-Up Studies | Atrial Fibrillation - therapy | Embolism - diagnosis | Humans | Risk Factors | Atrial Fibrillation - complications | Bradycardia - therapy | Male | Bradycardia - complications | Pacemaker, Artificial | Monitoring, Physiologic | Time Factors | Female | Aged | Embolism - etiology | Atrial Fibrillation - diagnosis | Hypertension | Medical research | Bradycardia | Analysis | Cardiac patients | Atrial fibrillation | Medicine, Experimental | Pacemaker, Artificial (Heart) | Anticoagulants (Medicine) | Cardiology | Stroke (Disease) | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Embolisms | Mortality | Multivariate analysis | Risk factors | Confidence intervals | Diabetes | Drug therapy
CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | RISK-FACTOR | WARFARIN | RANDOMIZED-TRIAL | PATTERNS | DEATH | PREVALENCE | Prospective Studies | Follow-Up Studies | Atrial Fibrillation - therapy | Embolism - diagnosis | Humans | Risk Factors | Atrial Fibrillation - complications | Bradycardia - therapy | Male | Bradycardia - complications | Pacemaker, Artificial | Monitoring, Physiologic | Time Factors | Female | Aged | Embolism - etiology | Atrial Fibrillation - diagnosis | Hypertension | Medical research | Bradycardia | Analysis | Cardiac patients | Atrial fibrillation | Medicine, Experimental | Pacemaker, Artificial (Heart) | Anticoagulants (Medicine) | Cardiology | Stroke (Disease) | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Embolisms | Mortality | Multivariate analysis | Risk factors | Confidence intervals | Diabetes | Drug therapy
Journal Article
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, ISSN 1552-4841, 01/2019, Volume 180, Issue 1, pp. 25 - 34
The 2017 nosology defines the new criteria for hypermobile Ehlers–Danlos syndrome (hEDS), which is now considered one end of a continuous spectrum encompassing...
Ehlers–Danlos syndrome | joint hypermobility | pain | quality of life | dysautonomia | coordination | Ehlers-Danlos syndrome | PSYCHIATRY | REPORT SCALE ASRS | FATIGUE | DEVELOPMENTAL COORDINATION DISORDER | CLASSIFICATION | TRANSLATION | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | SCREENING SCALE | NOSOLOGY | GENETICS & HEREDITY | GENERALIZED JOINT HYPERMOBILITY | Attention deficit disorder | Pain | Coordination | Autonomic nervous system | Attention deficit hyperactivity disorder | Classification | Fatigue | Children | Neurodevelopmental disorders | Quality of life
Ehlers–Danlos syndrome | joint hypermobility | pain | quality of life | dysautonomia | coordination | Ehlers-Danlos syndrome | PSYCHIATRY | REPORT SCALE ASRS | FATIGUE | DEVELOPMENTAL COORDINATION DISORDER | CLASSIFICATION | TRANSLATION | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | SCREENING SCALE | NOSOLOGY | GENETICS & HEREDITY | GENERALIZED JOINT HYPERMOBILITY | Attention deficit disorder | Pain | Coordination | Autonomic nervous system | Attention deficit hyperactivity disorder | Classification | Fatigue | Children | Neurodevelopmental disorders | Quality of life
Journal Article
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, ISSN 1552-4841, 09/2018, Volume 177, Issue 6, pp. 546 - 556
Joint hypermobility (JH) is a common, though largely ignored physical trait with increasing clinical reverberations. A few papers suggest a link between JH and...
Ehlers‐Danlos syndrome | joint hypermobility | attention deficit‐hyperactivity disorder | learning disorder | developmental coordination disorder | Ehlers-Danlos syndrome | attention deficit-hyperactivity disorder | CRITERIA | POPULATION | PROPRIOCEPTIVE ACUITY | GAIT | PSYCHIATRY | CLASSIFICATION | PREVALENCE | BALANCE | VARIABILITY | DIFFICULTIES | GENETICS & HEREDITY | EHLERS-DANLOS-SYNDROME | Learning disabilities | Genetic aspects | Apraxia | Children | Emotional behavior | Coordination | Attention deficit hyperactivity disorder | Cognitive ability | Neurodevelopmental disorders | Quality of life
Ehlers‐Danlos syndrome | joint hypermobility | attention deficit‐hyperactivity disorder | learning disorder | developmental coordination disorder | Ehlers-Danlos syndrome | attention deficit-hyperactivity disorder | CRITERIA | POPULATION | PROPRIOCEPTIVE ACUITY | GAIT | PSYCHIATRY | CLASSIFICATION | PREVALENCE | BALANCE | VARIABILITY | DIFFICULTIES | GENETICS & HEREDITY | EHLERS-DANLOS-SYNDROME | Learning disabilities | Genetic aspects | Apraxia | Children | Emotional behavior | Coordination | Attention deficit hyperactivity disorder | Cognitive ability | Neurodevelopmental disorders | Quality of life
Journal Article
American Heart Journal, ISSN 0002-8703, 2007, Volume 154, Issue 5, pp. 884 - 892
Introduction The experimental concept that “atrial fibrillation (AF) begets AF” implies that atrial tachyarrhythmia (AT)/AF burden uniformly increases over...
Cardiovascular | SITE | DDDR | CARDIAC & CARDIOVASCULAR SYSTEMS | TACHYARRHYTHMIA | PREVENTION | ABLATION | BRADYCARDIA | PACEMAKERS | ENALAPRIL | Prognosis | Follow-Up Studies | Humans | Tachycardia, Paroxysmal - physiopathology | Atrial Fibrillation - complications | Bradycardia - physiopathology | Male | Atrial Fibrillation - physiopathology | Bradycardia - complications | Disease Progression | Randomized Controlled Trials as Topic | Tachycardia, Paroxysmal - complications | Electrocardiography | Heart Rate - physiology | Female | Aged | Development and progression | Care and treatment | Atrial fibrillation | Heart | Disease prevention | Cardiac arrhythmia | Survival analysis | Heart attacks | Algorithms | Clinical trials | Cardiovascular disease
Cardiovascular | SITE | DDDR | CARDIAC & CARDIOVASCULAR SYSTEMS | TACHYARRHYTHMIA | PREVENTION | ABLATION | BRADYCARDIA | PACEMAKERS | ENALAPRIL | Prognosis | Follow-Up Studies | Humans | Tachycardia, Paroxysmal - physiopathology | Atrial Fibrillation - complications | Bradycardia - physiopathology | Male | Atrial Fibrillation - physiopathology | Bradycardia - complications | Disease Progression | Randomized Controlled Trials as Topic | Tachycardia, Paroxysmal - complications | Electrocardiography | Heart Rate - physiology | Female | Aged | Development and progression | Care and treatment | Atrial fibrillation | Heart | Disease prevention | Cardiac arrhythmia | Survival analysis | Heart attacks | Algorithms | Clinical trials | Cardiovascular disease
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2016, Volume 32, Issue S1, pp. 1 - 409
Journal Article
Rheumatology, ISSN 1462-0324, 10/2019, Volume 58, Issue 10, pp. 1722 - 1730
Abstract Objectives This study is aimed at identifying discrete severity classes among adults with hypermobile Ehlers–Danlos syndrome (hEDS)/hypermobility...
scoring | Ehlers-Danlos syndrome | severity class | NOSOLOGY | FATIGUE | joint hypermobility | SYMPTOMS | COMMON FEATURE | RHEUMATOLOGY | classification | NATURAL-HISTORY
scoring | Ehlers-Danlos syndrome | severity class | NOSOLOGY | FATIGUE | joint hypermobility | SYMPTOMS | COMMON FEATURE | RHEUMATOLOGY | classification | NATURAL-HISTORY
Journal Article
IEEE Transactions on Automatic Control, ISSN 0018-9286, 01/2014, Volume 59, Issue 1, pp. 107 - 119
Given two control Lyapunov functions (CLFs), a "merging" is a new CLF whose gradient is a positive combination of the gradients of the two parents CLFs. The...
Linear systems | stabilizability of linear differential inclusions | Merging | Composite control Lyapunov functions | Control systems | Robustness | Vectors | Linear matrix inequalities | Lyapunov methods | Stabilizability of linear differential inclusions | LINEAR-SYSTEMS | FEEDBACK-CONTROL | STABILITY | SETS | TIME-SYSTEMS | CONSTRAINED STABILIZATION | AUTOMATION & CONTROL SYSTEMS | ENGINEERING, ELECTRICAL & ELECTRONIC | Liapunov functions | Usage | Feedback control systems | Approximation theory | Design and construction | Methods
Linear systems | stabilizability of linear differential inclusions | Merging | Composite control Lyapunov functions | Control systems | Robustness | Vectors | Linear matrix inequalities | Lyapunov methods | Stabilizability of linear differential inclusions | LINEAR-SYSTEMS | FEEDBACK-CONTROL | STABILITY | SETS | TIME-SYSTEMS | CONSTRAINED STABILIZATION | AUTOMATION & CONTROL SYSTEMS | ENGINEERING, ELECTRICAL & ELECTRONIC | Liapunov functions | Usage | Feedback control systems | Approximation theory | Design and construction | Methods
Journal Article